Apixaban and rivaroxaban are the oral anticoagulants most frequently used to treat acute venous thromboembolism. However, uncertainty remains about the difference in bleeding risk between the two ...
Please provide your email address to receive an email when new articles are posted on . Surgical patient optimization focused on absolute risk empowers surgeons to make decisions and improve outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results